Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Celyad Oncology SA (CYAD)
Celyad Oncology SA (CYAD) Financials

CYAD Celyad Oncology SA

0.47

0.00 (0.00%)

May 02 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Return on Assets (%)	-15.825	-52.113	-43.539	-31.099	-22.068	-36.311	-82.15	-46.936
Return on Equity (%)	-23.331	-81.484	-72.586	-56.581	-44.911	-71.046	-170.719	-159.081
Return on Invested Capital (%)	-24.454	-72.535	-76.241	-59.546	-47.304	-78.45	-26.229	-360.168
Operating Margin (%)	-275.76	-1589.04	-1199.518	-471600	-338140	N/A	N/A	-8263.725
Net Profit Margin (%)	-276.968	-1593.079	-1201.509	-477200	-344080	N/A	N/A	-8282.353
Book Value Per Share	4.437	1.117	1.627	0.676	-0.371	0.331	0.153	0.143
Earnings Per Share	-2.535	-5.716	-3.134	-2.054	-1.234	-1.173	-1.812	-0.204
Cash Per Share	5.192	2.357	3.395	2.822	1.236	1.329	0.551	0.169
Working Capital Per Share	7.956	2.883	3.521	2.217	0.565	0.906	0.195	0.198
Operating Profit Per Share	1.444	0.573	0.351	0.4	1.002	0.255	1.066	0.035
EBIT Per Share	-2.535	-5.716	-3.134	-2.054	-1.234	-1.173	-1.809	-0.205
EBITDA Per Share	-2.535	-5.716	-3.134	-2.054	-1.234	-1.173	-1.809	-0.205
Free Cash Flow Per Share	-2.506	-5.802	-3.08	-2.137	-1.342	-1.223	-1.87	-0.201

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	7.571	4.581	5.359	3.593	1.665	2.48	1.422	3.793
Quick Ratio	7.33	4.276	5.185	3.313	1.47	2.186	1.281	2.518
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	9.31M	9.87M	11.94M	13.94M	13.94M	22.59M	22.59M	41.43M

Key Stats and Ratios

Year End December 30 2023	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022
	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)	EUR (€)
Shares Outstanding	N/A	13.94M	N/A	15.49M	N/A	22.59M	22.59M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	1.424	N/A	N/A	N/A	2.576
Quick Ratio	N/A	N/A	1.091	N/A	N/A	N/A	2.025
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	12.84M
Price to Earnings Ratio	-1.52
Price to Sales Ratio	124
Price to Cash Ratio	1.83
Price to Book Ratio	2.04
Dividend Yield	-

Share Statistics

Shares Outstanding	41.43M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Celyad Oncology

Delayed Upgrade Clock